Breaking News Instant updates and real-time market news.

ISRG

Intuitive Surgical

$510.88

28.02 (5.80%)

12:01
01/09/19
01/09
12:01
01/09/19
12:01

Piper remains buyer of Intuitive Surgical shares on 'undeniable' momentum

Piper Jaffray analyst JP McKim says this morning's preliminary Q4 results and 2019 procedure guidance from Intuitive Surgical were both better than expected. The "strong" 13%-17% procedure guidance for 2019 far exceeded expectations and the "strong" system placements is a great leading indicator for future procedure growth, McKim tells investors in a research note titled "Undeniable Strong Momentum In The Business; Remain Buyers Here." He believes Intuitive's momentum is "very strong" and remains a buyer of the shares. This "high quality franchise" needs to be owned in portfolios as surgeries shift from open to robotic, McKim contends. He keeps an Overweight rating on Intuitive Surgical with a $625 price target. The stock in midday trading is up 6%, or $30.89, to $513.88.

  • 09

    Jan

  • 24

    Jan

  • 27

    Jan

ISRG Intuitive Surgical
$510.88

28.02 (5.80%)

01/02/19
SBSH
01/02/19
NO CHANGE
SBSH
Citi makes four rating changes in Medical Devices, 'warning up' to J&J
Citi analyst Amit Hazan issued his 2019 preview for Medical Devices, which included four rating changes. The analyst upgraded both Zimmer Biomet (ZBH) and Baxter International (BAX) to Buy from Neutral, downgraded Medtronic (MDT) to Neutral from Buy and downgraded Abbott Laboratories (ABT) to Sell from Neutral. He also kept Buy ratings on Intuitive Surgical (ISRG) and Boston Scientific (BSX), but adds he's "relatively more cautious." Further, Hazan kept a Sell rating on Edwards Lifesciences (EW) and says he's "warming up" to Neutral-rated Johnson & Johnson (JNJ). The analyst expects "fairly stable" fundamentals for the group in 2019, with "modest slowdowns" in organic sales and earnings growth.
12/18/18
PIPR
12/18/18
NO CHANGE
PIPR
Piper lays out top Medical Technology picks heading into 2019
Piper Jaffray analyst Matt O'Brien tells investors to hold onto Medical Technology stocks into 2019. Multiples are unlikely to increase meaningfully next year, but they should hold given the continued solid fundamentals and strong new product cycles, O'Brien tells investors in a research note after taking a close look at the Med Tech sector. He believes Align Technology (ALGN), Inogen (INGN) and Nuvectra (NVTR) "could provide considerable alpha to investors willing to step up to the plate and buy now." Secondly, the analyst thinks Intuitive Surgical (ISRG) and Merit Medical (MMSI) "could provide a defensive bet in volatile markets."
12/13/18
PIPR
12/13/18
NO CHANGE
Target $625
PIPR
Overweight
Piper still sees 'strong growth' for Intuitive Surgical despite CMR competition
CMR Surgical and Florida Hospital's Nicholson Center launched the first U.S. based training program for CMR's Versius Robotic System, Piper Jaffray analyst JP McKim tells investors in a research note. CMR plans to launch the Versius system in the U.S. in 2019, which makes it the next round of competition for Intuitive Surgical, says the analyst. However, he believes that while the introduction of new systems in the U.S. is worth monitoring, moving from training to full commercial launch is "always challenging especially with how long the capital sales processes take." With an upgrade cycle underway and the introduction of new systems in SP and Ion, McKim continues to expect Intuitive Surgical to deliver "strong growth" in 2019. He keeps an Overweight rating on the shares with a $625 price target. The stock in midday trading is down $4.69 to $510.94.
12/10/18
MSCO
12/10/18
NO CHANGE
Target $620
MSCO
Overweight
Intuitive Surgical has room to top higher bar set for 2019, says Morgan Stanley
Morgan Stanley analyst David Lewis noted that the bar has been raised for Intuitive Surgical following two years of positive revisions to procedure growth and system placements. However, he believes the company still has room to beat expectations as he thinks the impact of hernia, Japan, China, and Ion may not be fully appreciated. He keeps an Overweight and $620 price target on Intuitive Surgical shares.

TODAY'S FREE FLY STORIES

MGLN

Magellan Health

$65.33

0.28 (0.43%)

11:05
02/20/19
02/20
11:05
02/20/19
11:05
Hot Stocks
Breaking Hot Stocks news story on Magellan Health »

Magellan Health jumps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

MGLN

Magellan Health

$65.33

0.28 (0.43%)

11:05
02/20/19
02/20
11:05
02/20/19
11:05
Periodicals
Breaking Periodicals news story on Magellan Health »

Magellan Health exploring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

WIX

Wix.com

$111.78

-13.92 (-11.07%)

11:05
02/20/19
02/20
11:05
02/20/19
11:05
Downgrade
Wix.com rating change  »

Rosenblatt downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 18

    Mar

TKC

Turkcell

$6.97

0.06 (0.87%)

11:02
02/20/19
02/20
11:02
02/20/19
11:02
Earnings
Turkcell reports FY net income 2.02B liras, consensus 1.93B liras »

Bloomberg reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 14

    Mar

  • 19

    Mar

VIA

Viacom

$34.98

0.13 (0.37%)

, VIAB

Viacom

$29.35

0.22 (0.76%)

11:02
02/20/19
02/20
11:02
02/20/19
11:02
Hot Stocks
Viacom, fuboTV announce distribution partnership »

Viacom and fuboTV…

VIA

Viacom

$34.98

0.13 (0.37%)

VIAB

Viacom

$29.35

0.22 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Feb

  • 04

    Mar

  • 11

    Mar

  • 11

    Mar

  • 11

    Mar

  • 11

    Mar

  • 06

    Jun

HRL

Hormel Foods

$42.86

-0.45 (-1.04%)

11:00
02/20/19
02/20
11:00
02/20/19
11:00
Options
Put buyers gobble up positions in Hormel Foods ahead of earnings »

Put buyers gobble up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

WIX

Wix.com

$112.09

-13.61 (-10.83%)

10:56
02/20/19
02/20
10:56
02/20/19
10:56
Downgrade
Wix.com rating change  »

Wix.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 18

    Mar

SJM

J.M. Smucker

$106.49

2.47 (2.37%)

10:54
02/20/19
02/20
10:54
02/20/19
10:54
Earnings
J.M. Smucker issues preliminary FY20 adjusted EPS growth outlook of 3%-4% »

In slides for its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 26

    Feb

SJM

J.M. Smucker

$106.08

2.06 (1.98%)

10:52
02/20/19
02/20
10:52
02/20/19
10:52
Hot Stocks
J.M. Smucker sees FY20 outlook helped by pet prices, hurt by peanut butter price »

In slides for its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 26

    Feb

ETM

Entercom

$7.73

0.22 (2.93%)

10:50
02/20/19
02/20
10:50
02/20/19
10:50
Options
Pre-earnings call buying in Entercom Communications »

Pre-earnings call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

SJM

J.M. Smucker

$106.00

1.98 (1.90%)

10:48
02/20/19
02/20
10:48
02/20/19
10:48
Earnings
J.M. Smucker repeats FY19 adjusted EPS view of $8.00-$8.20, consensus $8.01 »

In slides for its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 26

    Feb

TGEN

Tecogen

$3.84

(0.00%)

10:48
02/20/19
02/20
10:48
02/20/19
10:48
Hot Stocks
Tecogen secures $8.4M trigeneration project in Manhattan »

Tecogen announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKC

Turkcell

$6.97

0.06 (0.87%)

10:47
02/20/19
02/20
10:47
02/20/19
10:47
Hot Stocks
Breaking Hot Stocks news story on Turkcell »

Turkcell trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 14

    Mar

  • 19

    Mar

HON

Honeywell

$153.66

0.39 (0.25%)

10:43
02/20/19
02/20
10:43
02/20/19
10:43
Hot Stocks
Breaking Hot Stocks news story on Honeywell »

Honeywell says UOP will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 29

    Apr

HON

Honeywell

$153.66

0.39 (0.25%)

10:41
02/20/19
02/20
10:41
02/20/19
10:41
Hot Stocks
Honeywell says UOP has been 'very disciplined' on the cost side »

Says Honeywell UOP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 29

    Apr

FITB

Fifth Third

$27.49

-0.025 (-0.09%)

10:40
02/20/19
02/20
10:40
02/20/19
10:40
Options
Bearish option flow in Fifth Third Bancorp »

Bearish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 12

    Mar

10:40
02/20/19
02/20
10:40
02/20/19
10:40
General news
Money market rates have dipped »

Money market rates have…

10:35
02/20/19
02/20
10:35
02/20/19
10:35
Conference/Events
Morgan Stanley sports/footwear analyst to hold analyst/industry conference call »

Sports & Footwear…

KO

Coca-Cola

$44.99

0.17 (0.38%)

10:30
02/20/19
02/20
10:30
02/20/19
10:30
Options
Vote of confidence in Coca Cola »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

ARW

Arrow Electronics

$81.74

0.73 (0.90%)

10:28
02/20/19
02/20
10:28
02/20/19
10:28
Hot Stocks
Arrow Electronics CEO sells over $4.3M worth of shares »

Arrow Electronics CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

10:25
02/20/19
02/20
10:25
02/20/19
10:25
Conference/Events
Credit Suisse analysts to hold an analyst/industry conference call »

Analysts discuss the HOLT…

10:25
02/20/19
02/20
10:25
02/20/19
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

FLR

Fluor

$37.46

0.46 (1.24%)

, HAL

Halliburton

$32.29

0.59 (1.86%)

10:21
02/20/19
02/20
10:21
02/20/19
10:21
Hot Stocks
Fluor awarded Halliburton chemicals project in Saudi Arabia »

Fluor (FLR) announced…

FLR

Fluor

$37.46

0.46 (1.24%)

HAL

Halliburton

$32.29

0.59 (1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 15

    May

  • 22

    May

  • 28

    May

W

Wayfair

$120.90

0.67 (0.56%)

10:20
02/20/19
02/20
10:20
02/20/19
10:20
Hot Stocks
Hedgeye names Wayfair as new short idea »

Hedgeye named Wayfair as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

TSLA

Tesla

$304.20

-1.36 (-0.45%)

10:20
02/20/19
02/20
10:20
02/20/19
10:20
Options
Put buyers in Tesla weekly options »

Put buyers in Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.